ArticleBMC plant biology2025
Evaluation of Trichoderma bio-control agents and pre-cultivation seed treatments for the control of Cephalosporium maydis causing late wilt in maize (Zea mays L.).
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLate wilt disease, caused by Cephalosporium maydis, is one of the most aggressive fungal diseases threatening maize production in Egypt and Mediterranean region. Biological control and pre-cultivation seed treatments are proposed among the best strategies to control C. maydis under greenhouse and field conditions. The objective of this study was to evaluate the effectiveness of Trichoderma bio-control agents as well as several pre-cultivation seed treatments (priming and coating) in controlling late wilt disease and improving maize production. Five isolates of C. maydis were isolated from infected maize plants collected from different Egyptian governorates. In vitro and in vivo experiments were performed to evaluate the efficacy of different treatments in the control of C. maydis.
resultsPathogenicity test revealed that isolate (5) of C. maydis, collected from Qalyubia governorate, was the most virulent against the Baladi maize variety. In vitro, five Trichoderma isolates (T1, T2, T4, T6, and T7) were the most antagonistic against C. maydis. Seed germination tests showed that "extra seed power"- a novel seed treatment- applied by either coating or priming, along with priming with either garlic or moringa extracts significantly outperformed other treatments in enhancing maize germination and seedling parameters. In greenhouse, the lowest significant disease incidence percentages for Giza 168 maize cultivar were achieved with T2, ESP coating, ESP priming, T4, moringa leaf extract priming at 1.0%, Premis Ultra 2.5% fungicide and garlic extract priming at 1.0%, respectively. The same treatments recorded the lowest significant disease incidence percentages for the same maize cultivar under field conditions. The previous results were supported by anatomical investigation of maize stem under different treatments. Moreover, significant improvements in plant height and yield parameters such as ear weight and length, and grain yield were achieved with the same treatments under infection conditions.
conclusionBio-control treatments using T. asperellum (T2) and T. harzianum (T4) along with seed treatments using ESP by coating and priming were the most effective in reducing late wilt disease incidence and enhancing growth and yield parameters of maize under greenhouse and field conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.